Concepedia

Publication | Open Access

Aurora A Inhibitor (MLN8237) plus Vincristine plus Rituximab Is Synthetic Lethal and a Potential Curative Therapy in Aggressive B-cell Non-Hodgkin Lymphoma

DOIFull Paper Access

57

Citations

38

References

2012

Year

Daruka Mahadevan, A Stejskal, Laurence Cooke, Ann Manziello, Carla Morales, Daniel O. Persky, Richard I. Fisher, Thomas P. Miller, Wenqing Qi
Clinical Cancer Research

Abstract

Addition of rituximab to MV is a novel therapeutic strategy for aggressive B-NHL and warrants clinical trial evaluation.

References

YearCitations

Page 1